Antibody Screening Results for Anti-Nucleocapsid Antibodies Toward the Development of a Lateral Flow Assay to Detect SARS-CoV-2 Nucleocapsid Protein

[Image: see text] The global COVID-19 pandemic has created an urgent demand for large numbers of inexpensive, accurate, rapid, point-of-care diagnostic tests. Analyte-based assays are suitably rapid and inexpensive and can be rapidly mass-produced, but for sufficiently accurate performance, they req...

Descripción completa

Detalles Bibliográficos
Autores principales: Cate, David M., Bishop, Joshua D., Hsieh, Helen V., Glukhova, Veronika A., Alonzo, Luis F., Hermansky, H. Gleda, Barrios-Lopez, Brianda, Grant, Benjamin D., Anderson, Caitlin E., Spencer, Ethan, Kuhn, Samantha, Gallagher, Ryan, Rivera, Rafael, Bennett, Crissa, Byrnes, Samantha A., Connelly, John T., Dewan, Puneet K., Boyle, David S., Weigl, Bernhard H., Nichols, Kevin P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482319/
https://www.ncbi.nlm.nih.gov/pubmed/34608447
http://dx.doi.org/10.1021/acsomega.1c01253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482319/
https://www.ncbi.nlm.nih.gov/pubmed/34608447
http://dx.doi.org/10.1021/acsomega.1c01253

Ejemplares similares